text_1: New Therapy for Enlarged Prostate May Bypass Unpleasant Side Effects
text_2: Strong points:  there were several clear caveats, mostly from independent experts interviewed. Weaker points:  failure to evaluate the evidence, failure to put into appropriate context of other alternative treatments for which there is FAR more data and experience. Experimental outcomes need to be presented in a framework that avoids generating unrealistic expectations. There are many men who are affected with benign prostatic hyperplasia, so the information presented needs to do a better job of providing them with accurate, balanced, complete information that can facilitate a truly informed shared decision-making encounter with their doctors.